CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed
Drug / intervention
Neoral +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00286871
NCT00286871Phase 1Completed
CompareCT.gov

Steroid Avoidance in Hep C OLT

Duke University·interventional·Posted Feb 6, 2006·Updated Sep 22, 2014

In Brief

A Phase 1 clinical trial evaluating Neoral and Tacrolimus for Chronic Hepatitis C and 2 related conditions. Completed, across 1 site.

Detailed Summary

Liver transplant subjects will be given Mycophenolate (MMF) and Tacrolimus in order to help prevent post-transplant rejection.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Hepatitis C, Organ Transplantation, Immunosuppression
CountriesUnited States
CollaboratorsNovartis Pharmaceuticals

Timeline

Phase 1CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 6, 2006
Enrollment StartFeb 1, 2006
Study CompletionFeb 1, 2009
TodayJul 2, 2026
Posted 20.4 years ago

Interventions

Neoraldrug

Tacrolimusdrug